Effect of gatifloxacin against Mycoplasma genitalium-related urethritis: An open clinical trial

Sexually Transmitted Infections

Volumn 87, Issue 5, 2011, Pages 389-390

  Hamasuna, Ryoichi ^a,b,c   Takahashi, Satoshi ^b,d   Kiyota, Hiroshi ^b,e   Yasuda, Mitsuru ^b,f   Hayami, Hiroshi ^b,g   Arakawa, Soichi ^b,h   Tomono, Kazunori ⁱ   Matsumoto, Tetsuro ^a,b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Japanese Research Group for UTI   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d SAPPORO MEDICAL UNIVERSITY   (Japan)

^e Jikei University Katsushika Medical Center   (Japan)

^f GIFU UNIVERSITY   (Japan)

^g KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^h KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GATIFLOXACIN;

ADULT; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MICTURITION DISORDER; MYCOPLASMA GENITALIUM; NONHUMAN; NONSPECIFIC URETHRITIS; PRIORITY JOURNAL;

ADULT; AGED; ANTI-INFECTIVE AGENTS; DRUG ADMINISTRATION SCHEDULE; FLUOROQUINOLONES; HUMANS; MALE; MIDDLE AGED; MYCOPLASMA GENITALIUM; MYCOPLASMA INFECTIONS; TREATMENT OUTCOME; URETHRITIS; YOUNG ADULT;

EID: 79960697739     PISSN: 13684973     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/sti.2010.048553     Document Type: Article

References (10)

1. Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep 2010;59:1-110.
2. British Association for Sexual Health and HIV. Clinical Effectiveness Group: 2007 UK National guideline on the management of non-gonococcal urethritis, Update Dec 2008. http//www.bashh.org/guideline (accessed 21 Apr 2011).
3. Mena LA, Mroczkowski TF, Nsuami M, et al. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 2009;48:1649-54.
4. Bradshaw CS, Jensen JS, Tabrizi SN, et al. Azithromycin failure in Mycoplasma genitalium urethritis. Emerg Infect Dis 2006;12:1149-52. (Pubitemid 44061291)
5. Jensen JS, Bradshaw CS, Tabrizi SN, et al. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 2008;47:1546-53.
6. Hamasuna R, Jensen JS, Osada Y. Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR. Antimicrob Agents Chemother 2009;53:4938-9.
7. Maeda S, Tamaki M, Kubota Y, et al. Treatment of men with urethritis negative for Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum. Int J Urol 2007;14:422-5. (Pubitemid 46776219)
8. Fung-Tomc J, Minassian B, Kolek B, et al. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin. J Antimicrob Chemother 2000;45:437-46.
9. Anon. Determination that TEQUIN (gatifloxacin) was withdrawn from sale for reasons of safety or effectiveness. Fed Regit 2008;73:52357-8.
10. Jensen JS, Bjornelius E, Dohn B, et al. Use of TaqMan 5′ nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic. J Clin Microbiol 2004;42:683-92. (Pubitemid 38228388)